Changes to the Code
H.R. 9672 · Vaccine Injury Compensation Modernization Act of 2026 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
26 U.S.C. § 4131 Imposition of tax
1 change the bill asks for here, 1 carried out
- Carried out:
Section 4131(b)(1) of the Internal Revenue Code of 1986 is amended by striking
75 cents
and inserting$2.20
.
§ 4131(a)–(c)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 4131. Imposition of tax | § 4131. Imposition of tax | |||
| (a) | (a) General rule | (a) General rule | ||
| There is hereby imposed a tax on any taxable vaccine sold by the manufacturer, producer, or importer thereof. | There is hereby imposed a tax on any taxable vaccine sold by the manufacturer, producer, or importer thereof. | |||
| (b) | (b) Amount of tax | (b) Amount of tax | ||
| (b)(1) | (1) In general | (1) In general | ||
| The amount of the tax imposed by subsection (a) shall be | The amount of the tax imposed by subsection (a) shall be [inserted: $2.20] per dose of any taxable vaccine. | |||
| (b)(2) | (2) Combinations of vaccines | (2) Combinations of vaccines | ||
| If any taxable vaccine is described in more than 1 subparagraph of section 4132(a)(1), the amount of the tax imposed by subsection (a) on such vaccine shall be the sum of the amounts for the vaccines which are so included. | If any taxable vaccine is described in more than 1 subparagraph of section 4132(a)(1), the amount of the tax imposed by subsection (a) on such vaccine shall be the sum of the amounts for the vaccines which are so included. | |||
| (c) | (c) Application of section | (c) Application of section | ||
| The tax imposed by this section shall apply— | The tax imposed by this section shall apply— |
Rest of § 4131 unchanged
26 U.S.C. § 4132 Definitions and special rules
6 changes the bill asks for here, 6 carried out
- Carried out:
Section 4132(a)(1) of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:
(Q) Any vaccine against dengue..
- Carried out:
Section 4132(a)(1) of the Internal Revenue Code of 1986, as amended by subsection (a)(1), is amended by adding at the end the following new subparagraph:
(R) Any vaccine against SARS–CoV–2..
- Carried out:
Section 4132(a)(1) of the Internal Revenue Code of 1986, as amended by subsection (b)(1), is amended by adding at the end the following new subparagraph:
(S) Any vaccine against respiratory syncytial virus..
- Carried out:
Section 4132(a)(1) of the Internal Revenue Code of 1986, as amended by subsection (c)(1), is amended by adding at the end the following new subparagraph:
(T) Any vaccine against herpes zoster (shingles)..
- Carried out:
Section 4132(a)(1) of the Internal Revenue Code of 1986, as amended by subsection (d)(1), is amended by adding at the end the following new subparagraph:
(U) Any vaccine not described in this paragraph— (i) which either— (I) is licensed under section 351 of the Public Health Service Act, or (II) is authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act, and (ii) which is commercially distributed in the United States..
- Carried out:
Section 4132(a)(2) of the Internal Revenue Code of 1986 is amended by inserting
by stimulating active immunity or by providing passive immunity for long-term protection through long-acting monoclonal antibody products included in recommendations of the Advisory Committee on Immunization Practices that have been adopted by the Director of the Centers for Disease Control and Prevention
before the period.
§ 4132(a)Definitions relating to taxable vaccines(1)–(4)
Start of § 4132 to (a)(1)(N) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (1)(O) | (O) | (O) | ||
| Any meningococcal vaccine. | Any meningococcal vaccine. | |||
| (1)(P) | (P) | (P) | ||
| Any vaccine against the human papillomavirus. | Any vaccine against the human papillomavirus. | |||
| (1)(Q) | (Q) [inserted: ] | |||
| [inserted: Any vaccine against dengue.] | ||||
| (1)(R) | (R) [inserted: ] | |||
| [inserted: Any vaccine against SARS–CoV–2.] | ||||
| (1)(S) | (S) [inserted: ] | |||
| [inserted: Any vaccine against respiratory syncytial virus.] | ||||
| (1)(T) | (T) [inserted: ] | |||
| [inserted: Any vaccine against herpes zoster (shingles).] | ||||
| (1)(U) | (U) [inserted: ] | |||
| [inserted: Any vaccine not described in this paragraph—] | ||||
| (1)(U)(i) | (i) [inserted: ] | |||
| [inserted: which either—] | ||||
| (1)(U)(i)(I) | (I) [inserted: ] | |||
| [inserted: is licensed under section 351 of the Public Health Service Act, or] | ||||
| (1)(U)(i)(II) | (II) [inserted: ] | |||
| [inserted: is authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act, and] | ||||
| (1)(U)(ii) | (ii) [inserted: ] | |||
| [inserted: which is commercially distributed in the United States.] | ||||
| (2) | (2) Vaccine | (2) Vaccine | ||
| The term “vaccine” means any substance designed to be administered to a human being for the prevention of 1 or more diseases. | The term “vaccine” means any substance designed to be administered to a human being for the prevention of 1 or more diseases[inserted: by stimulating active immunity or by providing passive immunity for long-term protection through long-acting monoclonal antibody products included in recommendations of the Advisory Committee on Immunization Practices that have been adopted by the Director of the Centers for Disease Control and Prevention]. | |||
| (3) | (3) United States | (3) United States | ||
| The term “United States” has the meaning given such term by section 4612(a)(4). | The term “United States” has the meaning given such term by section 4612(a)(4). | |||
| (4) | (4) Importer | (4) Importer | ||
| The term “importer” means the person entering the vaccine for consumption, use, or warehousing. | The term “importer” means the person entering the vaccine for consumption, use, or warehousing. | |||
Rest of § 4132 unchanged
42 U.S.C. § 300aa–11 Petitions for compensation
1 change the bill asks for here, 1 carried out
- Carried out:
Section 2111(a)(2)(A) of the Public Health Service Act (42 U.S.C. 300aa–11(a)(2)(A)) is amended, in the matter preceding clause (i), by inserting
that includes the medical records and other information required under subsection (c) (including, if applicable, an identification of unavailable records and explanation of unavailability pursuant to subsection (c)(3))
afterunless a petition
.
§ 300aa–11(a)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 300aa–11. Petitions for compensation | § 300aa–11. Petitions for compensation | |||
| (a) | (a) General rule | (a) General rule | ||
| (a)(1) | (1) | (1) | ||
| A proceeding for compensation under the Program for a vaccine-related injury or death shall be initiated by service upon the Secretary and the filing of a petition containing the matter prescribed by subsection (c) with the United States Court of Federal Claims. The clerk of the United States Court of Federal Claims shall immediately forward the filed petition to the chief special master for assignment to a special master under section 300aa–12(d)(1) of this title. | A proceeding for compensation under the Program for a vaccine-related injury or death shall be initiated by service upon the Secretary and the filing of a petition containing the matter prescribed by subsection (c) with the United States Court of Federal Claims. The clerk of the United States Court of Federal Claims shall immediately forward the filed petition to the chief special master for assignment to a special master under section 300aa–12(d)(1) of this title. | |||
| (a)(2) | (2) | (2) | ||
| (a)(2)(A) | (A) | (A) | ||
| No person may bring a civil action for damages in an amount greater than $1,000 or in an unspecified amount against a vaccine administrator or manufacturer in a State or Federal court for damages arising from a vaccine-related injury or death associated with the administration of a vaccine after October 1, 1988, and no such court may award damages in an amount greater than $1,000 in a civil action for damages for such a vaccine-related injury or death, unless a petition has been filed, in accordance with section 300aa–16 of this title, for compensation under the Program for such injury or death and— | No person may bring a civil action for damages in an amount greater than $1,000 or in an unspecified amount against a vaccine administrator or manufacturer in a State or Federal court for damages arising from a vaccine-related injury or death associated with the administration of a vaccine after October 1, 1988, and no such court may award damages in an amount greater than $1,000 in a civil action for damages for such a vaccine-related injury or death, unless a petition [inserted: that includes the medical records and other information required under subsection (c) (including, if applicable, an identification of unavailable records and explanation of unavailability pursuant to subsection (c)(3)) ]has been filed, in accordance with section 300aa–16 of this title, for compensation under the Program for such injury or death and— | |||
| (a)(2)(A)(i) | (i) | (i) | ||
| (a)(2)(A)(i)(I) | (I) | (I) | ||
| the United States Court of Federal Claims has issued a judgment under section 300aa–12 of this title on such petition, and | the United States Court of Federal Claims has issued a judgment under section 300aa–12 of this title on such petition, and |
Rest of § 300aa–11 unchanged
42 U.S.C. § 300aa–12 Court jurisdiction
5 changes the bill asks for here, 5 carried out
- Carried out:
Section 2112(c)(1) of the Public Health Service Act (42 U.S.C. 300aa–12(c)(1)) is amended by striking
not more than 8
and insertingnot less than 10
. - Carried out:
Section 2112(c)(4) of the Public Health Service Act (42 U.S.C. 300aa–12(c)(4)) is amended to read as follows:
(4) The appointment of any individual as a special master shall be for an initial term of 4 years, subject to termination under paragraphs (2) and (3). An individual appointed as special master may be reappointed to serve one or more additional terms of up to 8 years each, …
- Carried out:
by inserting after
disposition of petitions,
the following:the number of petitions filed that are pending disposition, the number of hearings scheduled with respect to a pending disposition,
; and - Carried out:
by inserting
, including recommendations on whether additional special masters are needed to ensure an expeditious and fair resolution of petitions or otherwise improve the Program
afterin the Program
. - Carried out:
Section 2112(d)(3)(A)(ii) of the Public Health Service Act (42 U.S.C. 300aa–12(d)(3)(A)(ii)) is amended by striking
the petition was filed
and insertingon which the petition and the medical records and other information required to be filed with such petition under section 2111(c) was filed
.
§ 300aa–12(b)–(c)
Start of § 300aa–12 to (b)(2)(A) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (b)(2)(B) | (B) | (B) | ||
| relating to any allegation in a petition with respect to the matters described in section 300aa–11(c)(1)(C)(ii) of this title. | relating to any allegation in a petition with respect to the matters described in section 300aa–11(c)(1)(C)(ii) of this title. | |||
| (c) | (c) United States Court of Federal Claims special masters | (c) United States Court of Federal Claims special masters | ||
| (c)(1) | (1) | (1) | ||
| There is established within the United States Court of Federal Claims an office of special masters which shall consist of not | There is established within the United States Court of Federal Claims an office of special masters which shall consist of not [inserted: less] than [inserted: 10] special masters. The judges of the United States Court of Federal Claims shall appoint the special masters, 1 of whom, by designation of the judges of the United States Court of Federal Claims, shall serve as chief special master. The appointment and reappointment of the special masters shall be by the concurrence of a majority of the judges of the court. | |||
| (c)(2) | (2) | (2) | ||
| The chief special master and other special masters shall be subject to removal by the judges of the United States Court of Federal Claims for incompetency, misconduct, or neglect of duty or for physical or mental disability or for other good cause shown. | The chief special master and other special masters shall be subject to removal by the judges of the United States Court of Federal Claims for incompetency, misconduct, or neglect of duty or for physical or mental disability or for other good cause shown. | |||
| (c)(3) | (3) | (3) | ||
| A special master’s office shall be terminated if the judges of the United States Court of Federal Claims determine, upon advice of the chief special master, that the services performed by that office are no longer needed. | A special master’s office shall be terminated if the judges of the United States Court of Federal Claims determine, upon advice of the chief special master, that the services performed by that office are no longer needed. | |||
| (c)(4) | (4) | (4) | ||
| The appointment of any individual as a special master shall be for | The appointment of any individual as a special master shall be for [inserted: an] [inserted: initial ]term of 4 years, subject to termination under paragraphs (2) and (3). [inserted: An] [inserted: individual] [inserted: appointed ]as special [inserted: master] [inserted: may] [inserted: be] [inserted: reappointed] [inserted: to] serve [inserted: one] [inserted: or] [inserted: more] [inserted: additional] [inserted: terms] of [inserted: up] to [inserted: 8] [inserted: years] [inserted: each], [inserted: pursuant] to [inserted: paragraph] [inserted: (1)], [inserted: and ]subject to termination under paragraphs (2) and (3). | |||
| (c)(5) | (5) | (5) | ||
| The compensation of the special masters shall be determined by the judges of the United States Court of Federal Claims, upon advice of the chief special master. The salary of the chief special master shall be the annual rate of basic pay for level IV of the Executive Schedule, as prescribed by section 5315, title 5. The salaries of the other special masters shall not exceed the annual rate of basic pay of level V of the Executive Schedule, as prescribed by section 5316, title 5. | The compensation of the special masters shall be determined by the judges of the United States Court of Federal Claims, upon advice of the chief special master. The salary of the chief special master shall be the annual rate of basic pay for level IV of the Executive Schedule, as prescribed by section 5315, title 5. The salaries of the other special masters shall not exceed the annual rate of basic pay of level V of the Executive Schedule, as prescribed by section 5316, title 5. | |||
| (c)(6) | (6) | (6) | ||
| The chief special master shall be responsible for the following: | The chief special master shall be responsible for the following: |
§ 300aa–12(c)–(d)
(c)(6)(A)–(C) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (c)(6)(D) | (D) | (D) | ||
| Coordinating with the United States Court of Federal Claims the use of services, equipment, personnel, information, and facilities of the United States Court of Federal Claims without reimbursement. | Coordinating with the United States Court of Federal Claims the use of services, equipment, personnel, information, and facilities of the United States Court of Federal Claims without reimbursement. | |||
| (c)(6)(E) | (E) | (E) | ||
| Reporting annually to the Congress and the judges of the United States Court of Federal Claims on the number of petitions filed under section 300aa–11 of this title and their disposition, the dates on which the vaccine-related injuries and deaths for which the petitions were filed occurred, the types and amounts of awards, the length of time for the disposition of petitions, the cost of administering the Program, and recommendations for changes in the Program. | Reporting annually to the Congress and the judges of the United States Court of Federal Claims on the number of petitions filed under section 300aa–11 of this title and their disposition, the dates on which the vaccine-related injuries and deaths for which the petitions were filed occurred, the types and amounts of awards, the length of time for the disposition of petitions, the [inserted: number of petitions filed that are pending disposition, the number of hearings scheduled with respect to a pending disposition, the ]cost of administering the Program, and recommendations for changes in the Program[inserted: , including recommendations on whether additional special masters are needed to ensure an expeditious and fair resolution of petitions or otherwise improve the Program]. | |||
| (d) | (d) Special masters | (d) Special masters | ||
| (d)(1) | (1) | (1) | ||
| Following the receipt and filing of a petition under section 300aa–11 of this title, the clerk of the United States Court of Federal Claims shall forward the petition to the chief special master who shall designate a special master to carry out the functions authorized by paragraph (3). | Following the receipt and filing of a petition under section 300aa–11 of this title, the clerk of the United States Court of Federal Claims shall forward the petition to the chief special master who shall designate a special master to carry out the functions authorized by paragraph (3). |
§ 300aa–12(d)(3)(A)–(B)
(d)(2)–(3) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (A)(i) | (i) | (i) | ||
| include findings of fact and conclusions of law, and | include findings of fact and conclusions of law, and | |||
| (A)(ii) | (ii) | (ii) | ||
| be issued as expeditiously as practicable but not later than 240 days, exclusive of suspended time under subparagraph (C), after the date the petition was filed. | be issued as expeditiously as practicable but not later than 240 days, exclusive of suspended time under subparagraph (C), after the date [inserted: on which ]the petition [inserted: and the medical records and other information required to be filed with such petition under section 2111(c) ]was filed. | |||
| (A) | The decision of the special master may be reviewed by the United States Court of Federal Claims in accordance with subsection (e). | The decision of the special master may be reviewed by the United States Court of Federal Claims in accordance with subsection (e). | ||
| (B) | (B) | (B) | ||
| In conducting a proceeding on a petition a special master— | In conducting a proceeding on a petition a special master— |
Rest of § 300aa–12 unchanged
42 U.S.C. § 300aa–14 Vaccine Injury Table
3 changes the bill asks for here, 3 carried out
- Carried out:
by striking
routine administration to children
and insertingadministration to children, adults, or pregnant women
; and - Carried out:
by striking
within 2 years of
and insertingwithin 6 months of
; and - Carried out:
in subparagraph (A), by striking
routine administration to children
and insertingadministration to children, adults, or pregnant women
.
§ 300aa–14(e)Additional vaccines(1)–(3)
Start of § 300aa–14 to (e)(1)(B) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (1)(C) | (C) | (C) | ||
| the time period in which the first symptoms or manifestations of onset or other significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines may occur. | the time period in which the first symptoms or manifestations of onset or other significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines may occur. | |||
| (2) | (2) Vaccines recommended after August 1, 1993 | (2) Vaccines recommended after August 1, 1993 | ||
| When after August 1, 1993, the Centers for Disease Control and Prevention recommends a vaccine to the Secretary for | When after August 1, 1993, the Centers for Disease Control and Prevention recommends a vaccine to the Secretary for administration to children, [inserted: adults, or pregnant women, ]the Secretary shall, within [inserted: 6] [inserted: months] of such recommendation, amend the Vaccine Injury Table included in subsection (a) to include— | |||
| (2)(A) | (A) | (A) | ||
| vaccines which were recommended for | vaccines which were recommended for administration to children,[inserted: adults, or pregnant women,] | |||
| (2)(B) | (B) | (B) | ||
| the injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines, and | the injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines, and | |||
| (2)(C) | (C) | (C) | ||
| the time period in which the first symptoms or manifestations of onset or other significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines may occur. | the time period in which the first symptoms or manifestations of onset or other significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths associated with such vaccines may occur. | |||
| (3) | (3) Vaccines recommended for use in pregnant women | (3) Vaccines recommended for use in pregnant women | ||
| The Secretary shall revise the Vaccine Injury Table included in subsection (a), through the process described in subsection (c), to include vaccines recommended by the Centers for Disease Control and Prevention for routine administration in pregnant women and the information described in subparagraphs (B) and (C) of paragraph (2) with respect to such vaccines. | The Secretary shall revise the Vaccine Injury Table included in subsection (a), through the process described in subsection (c), to include vaccines recommended by the Centers for Disease Control and Prevention for routine administration in pregnant women and the information described in subparagraphs (B) and (C) of paragraph (2) with respect to such vaccines. |
42 U.S.C. § 300aa–15 Compensation
3 changes the bill asks for here, 3 carried out
- Carried out:
Section 2115(a)(2) of the Public Health Service Act (42 U.S.C. 300aa–15(a)(2)) is amended to read as follows:
(2) In the event of a vaccine-related death, an award of $600,000..
- Carried out:
Section 2115(a)(4) of the Public Health Service Act (42 U.S.C. 300aa–15(a)(4)) is amended to read as follows:
(4) For actual and projected pain and suffering and emotional distress from the vaccine-related injury, an award not to exceed $600,000..
- Carried out:
Section 2115(g) of the Public Health Service Act (42 U.S.C. 300aa–15(g)) is amended by striking the period at the end and inserting , or (3) under the Countermeasures Injury Compensation Program under sections 319F–3 and 319F–4, which shall be considered a concurrent remedy
.
Sections 319F–3 and 319F–4 shall not otherwise impact the availability of compensation under this Act, with respect to a vaccine-related injury or vaccine-related death.
§ 300aa–15(a)–(b)
Start of § 300aa–15 to (a)(1)(B)(ii) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (a)(1)(B)(iii) | (iii) | (iii) | ||
| were for diagnosis, medical or other remedial care, rehabilitation, developmental evaluation, special education, vocational training and placement, case management services, counseling, emotional or behavioral therapy, residential and custodial care and service expenses, special equipment, related travel expenses, and facilities determined to be reasonably necessary. | were for diagnosis, medical or other remedial care, rehabilitation, developmental evaluation, special education, vocational training and placement, case management services, counseling, emotional or behavioral therapy, residential and custodial care and service expenses, special equipment, related travel expenses, and facilities determined to be reasonably necessary. | |||
| (a)(2) | (2) | (2) | ||
| In the event of a vaccine-related death, an award of $ | In the event of a vaccine-related death, an award of $[inserted: 600],000. | |||
| (a)(3) | (3) | (3) | ||
| (a)(3)(A) | (A) | (A) | ||
| In the case of any person who has sustained a vaccine-related injury after attaining the age of 18 and whose earning capacity is or has been impaired by reason of such person’s vaccine-related injury for which compensation is to be awarded, compensation for actual and anticipated loss of earnings determined in accordance with generally recognized actuarial principles and projections. | In the case of any person who has sustained a vaccine-related injury after attaining the age of 18 and whose earning capacity is or has been impaired by reason of such person’s vaccine-related injury for which compensation is to be awarded, compensation for actual and anticipated loss of earnings determined in accordance with generally recognized actuarial principles and projections. | |||
| (a)(3)(B) | (B) | (B) | ||
| In the case of any person who has sustained a vaccine-related injury before attaining the age of 18 and whose earning capacity is or has been impaired by reason of such person’s vaccine-related injury for which compensation is to be awarded and whose vaccine-related injury is of sufficient severity to permit reasonable anticipation that such person is likely to suffer impaired earning capacity at age 18 and beyond, compensation after attaining the age of 18 for loss of earnings determined on the basis of the average gross weekly earnings of workers in the private, non-farm sector, less appropriate taxes and the average cost of a health insurance policy, as determined by the Secretary. | In the case of any person who has sustained a vaccine-related injury before attaining the age of 18 and whose earning capacity is or has been impaired by reason of such person’s vaccine-related injury for which compensation is to be awarded and whose vaccine-related injury is of sufficient severity to permit reasonable anticipation that such person is likely to suffer impaired earning capacity at age 18 and beyond, compensation after attaining the age of 18 for loss of earnings determined on the basis of the average gross weekly earnings of workers in the private, non-farm sector, less appropriate taxes and the average cost of a health insurance policy, as determined by the Secretary. | |||
| (a)(4) | (4) | (4) | ||
| For actual and projected pain and suffering and emotional distress from the vaccine-related injury, an award not to exceed $ | For actual and projected pain and suffering and emotional distress from the vaccine-related injury, an award not to exceed $[inserted: 600],000. | |||
| (b) | (b) Vaccines administered before effective date | (b) Vaccines administered before effective date | ||
| Compensation awarded under the Program to a petitioner under section 300aa–11 of this title for a vaccine-related injury or death associated with the administration of a vaccine before October 1, 1988, may include the compensation described in paragraphs (1)(A) and (2) of subsection (a) and may also include an amount, not to exceed a combined total of $30,000, for— | Compensation awarded under the Program to a petitioner under section 300aa–11 of this title for a vaccine-related injury or death associated with the administration of a vaccine before October 1, 1988, may include the compensation described in paragraphs (1)(A) and (2) of subsection (a) and may also include an amount, not to exceed a combined total of $30,000, for— | |||
| (b)(1) | (1) | (1) | ||
| lost earnings (as provided in paragraph (3) of subsection (a)), | lost earnings (as provided in paragraph (3) of subsection (a)), |
§ 300aa–15(f)–(h)
(b)(2)–(f)(4) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (f)(4)(C) | (C) | (C) | ||
| In purchasing an annuity under subparagraph (A) or (B), the Secretary may purchase a guarantee for the annuity, may enter into agreements regarding the purchase price for and rate of return of the annuity, and may take such other actions as may be necessary to safeguard the financial interests of the United States regarding the annuity. Any payment received by the Secretary pursuant to the preceding sentence shall be paid to the Vaccine Injury Compensation Trust Fund established under section 9510 of title 26, or to the appropriations account from which the funds were derived to purchase the annuity, whichever is appropriate. | In purchasing an annuity under subparagraph (A) or (B), the Secretary may purchase a guarantee for the annuity, may enter into agreements regarding the purchase price for and rate of return of the annuity, and may take such other actions as may be necessary to safeguard the financial interests of the United States regarding the annuity. Any payment received by the Secretary pursuant to the preceding sentence shall be paid to the Vaccine Injury Compensation Trust Fund established under section 9510 of title 26, or to the appropriations account from which the funds were derived to purchase the annuity, whichever is appropriate. | |||
| (g) | (g) Program not primarily liable | (g) Program not primarily liable | ||
| Payment of compensation under the Program shall not be made for any item or service to the extent that payment has been made, or can reasonably be expected to be made, with respect to such item or service (1) under any State compensation program, under an insurance policy, or under any Federal or State health benefits program (other than under title XIX of the Social Security Act [42 U.S.C. 1396 et seq.]), or (2) by an entity which provides health services on a prepaid basis. | Payment of compensation under the Program shall not be made for any item or service to the extent that payment has been made, or can reasonably be expected to be made, with respect to such item or service (1) under any State compensation program, under an insurance policy, or under any Federal or State health benefits program (other than under title XIX of the Social Security Act [42 U.S.C. 1396 et seq.]), or (2) by an entity which provides health services on a prepaid basis[inserted: , or (3) under the Countermeasures Injury Compensation Program under sections 319F–3 and 319F–4, which shall be considered a concurrent remedy].[inserted: Sections 319F–3 and 319F–4 shall not otherwise impact the availability of compensation under this Act, with respect to a vaccine-related injury or vaccine-related death] | |||
| (h) | (h) Liability of health insurance carriers, prepaid health plans, and benefit providers | (h) Liability of health insurance carriers, prepaid health plans, and benefit providers | ||
| No policy of health insurance may make payment of benefits under the policy secondary to the payment of compensation under the Program and— | No policy of health insurance may make payment of benefits under the policy secondary to the payment of compensation under the Program and— | |||
| (h)(1) | (1) | (1) | ||
| no State, and | no State, and |
Rest of § 300aa–15 unchanged
42 U.S.C. § 300aa–16 Limitations of actions
1 change the bill asks for here, 1 carried out
- Carried out:
Section 2116(a)(2) of the Public Health Service Act (42 U.S.C. 300aa–16(a)(2)) is amended by striking
36 months
and inserting5 years
.
§ 300aa–16(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 300aa–16. Limitations of actions | § 300aa–16. Limitations of actions | |||
| (a) | (a) General rule | (a) General rule | ||
| In the case of— | In the case of— | |||
| (a)(1) | (1) | (1) | ||
| a vaccine set forth in the Vaccine Injury Table which is administered before October 1, 1988, if a vaccine-related injury or death occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such injury or death after the expiration of 28 months after October 1, 1988, and no such petition may be filed if the first symptom or manifestation of onset or of the significant aggravation of such injury occurred more than 36 months after the date of administration of the vaccine, | a vaccine set forth in the Vaccine Injury Table which is administered before October 1, 1988, if a vaccine-related injury or death occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such injury or death after the expiration of 28 months after October 1, 1988, and no such petition may be filed if the first symptom or manifestation of onset or of the significant aggravation of such injury occurred more than 36 months after the date of administration of the vaccine, | |||
| (a)(2) | (2) | (2) | ||
| a vaccine set forth in the Vaccine Injury Table which is administered after October 1, 1988, if a vaccine-related injury occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such injury after the expiration of | a vaccine set forth in the Vaccine Injury Table which is administered after October 1, 1988, if a vaccine-related injury occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such injury after the expiration of [inserted: 5] [inserted: years] after the date of the occurrence of the first symptom or manifestation of onset or of the significant aggravation of such injury, and | |||
| (a)(3) | (3) | (3) | ||
| a vaccine set forth in the Vaccine Injury Table which is administered after October 1, 1988, if a death occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such death after the expiration of 24 months from the date of the death and no such petition may be filed more than 48 months after the date of the occurrence of the first symptom or manifestation of onset or of the significant aggravation of the injury from which the death resulted. | a vaccine set forth in the Vaccine Injury Table which is administered after October 1, 1988, if a death occurred as a result of the administration of such vaccine, no petition may be filed for compensation under the Program for such death after the expiration of 24 months from the date of the death and no such petition may be filed more than 48 months after the date of the occurrence of the first symptom or manifestation of onset or of the significant aggravation of the injury from which the death resulted. | |||
| (b) | (b) Effect of revised table | (b) Effect of revised table | ||
| If at any time the Vaccine Injury Table is revised and the effect of such revision is to permit an individual who was not, before such revision, eligible to seek compensation under the Program, or to significantly increase the likelihood of obtaining compensation, such person may, notwithstanding section 300aa–11(b)(2) of this title, file a petition for such compensation not later than 2 years after the effective date of the revision, except that no compensation may be provided under the Program with respect to a vaccine-related injury or death covered under the revision of the table if— | If at any time the Vaccine Injury Table is revised and the effect of such revision is to permit an individual who was not, before such revision, eligible to seek compensation under the Program, or to significantly increase the likelihood of obtaining compensation, such person may, notwithstanding section 300aa–11(b)(2) of this title, file a petition for such compensation not later than 2 years after the effective date of the revision, except that no compensation may be provided under the Program with respect to a vaccine-related injury or death covered under the revision of the table if— |
Rest of § 300aa–16 unchanged